A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 856
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CDAI
Long Form : Crohn's Disease Activity Index
No. Year Title Co-occurring Abbreviation
2019 Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure. AUC, CRP, IFX
2019 Antibiotics for induction and maintenance of remission in Crohn's disease. AEs, anti-TNF, CD, MD, RCTs, RR
2019 Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn's disease. ADC, CD, ES-CD
2019 Are key cytokines genetic and serum levels variations related to rheumatoid arthritis clinical severity? CBA, RA
2019 Assessment of bioelectrical phase angle as a predictor of nutritional status in patients with Crohn's disease: A cross sectional study. BC, CD, FFM, HGS, PhA
2019 Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early, Poor Prognosis Rheumatoid Arthritis. AVERT, MRI, MTX, RA, SDAI, SDAI
2019 Certolizumab pegol for induction of remission in Crohn's disease. CD, CZP, RR
2019 Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-alpha inhibitor in Crohn disease patients. CD, CRP, ELISA, HCs, IFX, IL, JNK, TNF
2019 Clinical outcomes of patients with active rheumatoid arthritis with normal acute phase reactant values. APR, CRP, ESR, HAQ-DI, KORONA, RA
10  2019 Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry. ACPAs, bDMARDs, RA, TNFis
11  2019 Comparison of Lewis Score and Capsule Endoscopy Crohn's Disease Activity Index in Patients with Crohn's Disease. CD, CECDAI, LS, SBCE
12  2019 Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn's disease under treatment. CD, GHAS, MH, SES-CD
13  2019 Current diagnosis and management of Crohn's disease in China: results from a multicenter prospective disease registry. CD
14  2019 Cytokines (IL-15, IL-21, and IFN-gamma) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity. CS, DAS28-ESR, RA, SDAI
15  2019 Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study. MTX, RA, TCZ
16  2019 Disease-related outcomes influence prevalence of falls in people with rheumatoid arthritis. BBS, FFI, HAQ-DI, ORs, RA, TUG
17  2019 Effect of a concomitant elemental diet with maintenance anti-tumor necrosis factor-alpha antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study. anti-TNF, ED
18  2019 Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn's disease or ulcerative colitis. AEs, CD, LOCF, OC, pCAI, QOL, SIBDQ, UC
19  2019 Effects of Language, Insurance, and Race/Ethnicity on Measurement Properties of the PROMIS Physical Function Short Form 10a in Rheumatoid Arthritis. PF10a, PROMIS, RA
20  2019 Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies. CD, CR, HBI, PRO
21  2019 Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study. ---
22  2019 Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia-Pacific region: Post-hoc analyses of pooled clinical study data. ACR, AEs, IRs, LTE, RA
23  2019 Efficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature. DMARDs, mRSS, RA, SSc
24  2019 Evaluating the effectiveness of infliximab on perianal fistulizing Crohn's disease by magnetic resonance imaging. IFX, MRI, PCDAI, PFCD
25  2019 Evaluation of Learned Helplessness, Perceived Self-efficacy, and Functional Capacity in Patients With Fibromyalgia and Rheumatoid Arthritis. FIQ, FM, HAQ, LH, RA, SE
26  2019 Frailty in seropositive rheumatoid arthritis patients of working age: a cross-sectional study. RA, SHARE-FI
27  2019 General synovitis score and immunologic synovitis score reflect clinical disease activity in patients with advanced stage rheumatoid arthritis. DMARDs, GSS, IMSYC, RA
28  2019 High prevalence of non-alcoholic fatty liver disease in patients with inflammatory bowel disease receiving anti-tumor necrosis factor therapy. IBD, NAFLD, TNF
29  2019 Influence of seasonal changes on disease activity and distribution of affected joints in rheumatoid arthritis. DAS, SDAI
30  2019 Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment. RA
31  2019 Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis. DMARD, FDG, PET-CT, RA, SUV, SUV
32  2019 Novel Microbial-Based Immunotherapy Approach for Crohn's Disease. CD
33  2019 Obesity Impacts Swelling of Ankle and Foot Joints in Early Rheumatoid Arthritis Patients. ACR, BMI, DAS, ESR, LE, RA, SJC
34  2019 Outcomes of infliximab dose escalation in patients with rheumatoid arthritis. HAQ, RA
35  2019 Pain and Catastrophizing in Patients With Rheumatoid Arthritis: An Observational Cohort Study. DMARD, PCS
36  2019 Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice. RA, TCZ
37  2019 Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis. ACR, DAS-28 ESR, FM, PGA, PSD, RA, VAS
38  2019 Predicting Post-operative Complications in Crohn's Disease: an Appraisal of Clinical Scoring Systems and the NSQIP Surgical Risk Calculator. HBI, NSQIP-SRC, SES-CD
39  2019 Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor. IQR, LDA, mHAQ, PsA, TNF
40  2019 Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study. DAS28, FAA, MTP, RA, RAPID3, SDAI
41  2019 Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden. SDAI, SR
42  2019 Pro- and anti-inflammatory eicosanoids in psoriatic arthritis. BSA, DAS, EPA, PsA
43  2019 Prognostic factors of budesonide therapy for the management of Crohn's disease: A meta-analysis. CI
44  2019 PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis. RA, SFs
45  2019 Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II). CD, IL-6, OLE, TNF
46  2019 Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease. CD, CI, IBD, RR, UC
47  2019 Remission induction, maintenance, and endoscopic outcome with oral 5-aminosalicylic acid in intestinal Behcet's disease. 5-ASA, BD
48  2019 Responsiveness of Patient-Reported Outcomes Measurement Information System Measures in Rheumatoid Arthritis Patients Starting or Switching a Disease-Modifying Antirheumatic Drug. DMARD, PROMIS, RA
49  2019 Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study. ---
50  2019 Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response. MTX, SJC, TJC
51  2019 Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial. csDMARD
52  2019 Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice. mTSS, RA
53  2019 Sustained clinical remission of rheumatoid arthritis and its predictive factors in an unselected adult Chinese population from 2009 to 2018. 6-month SR, DAS28-ESR, RA, SDAI, SR
54  2019 Systematic review: outcomes and adverse events from randomised trials in Crohn's disease. RCTs
55  2019 The add-on effectiveness and safety of iguratimod in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab. csDMARDs, DAS28-CRP, IGU, mHAQ, MTX, PSL, RA, RF, SASP, TAC, TCZ
56  2019 The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA). AmE, AmE-FLARE-RA, FLARE-RA, RA, RAPID3, TJC, VAS
57  2019 The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab. DAS28, Hb, NLR, PLR, PLT, RA, TCZ
58  2019 The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis. ACR, bDMARDs, DAS28, EULAR, LDA, RA
59  2019 The prevalence and types of discordance between physician perception and objective data from standardized measures of rheumatoid arthritis disease activity in real-world clinical practice in the US. DSP, RA
60  2019 The Relationship between Serum Bilirubin and Inflammatory Bowel Disease. CD, CRP, ESR, FC, Hb, IBD, STB, UC
61  2019 Three Quality Improvement Initiatives Improved Performance of Rheumatoid Arthritis Disease Activity Measures in Electronic Health Records: Results from an Interrupted Time Series Study. EHRs, RA
62  2019 Tocilizumab and rituximab have similar effectiveness and are both superior to a second tumour necrosis factor inhibitor in rheumatoid arthritis patients who discontinued a first TNF inhibitor. RTX, TCZ, TNFi
63  2019 Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity and the Probability of Achieving Low Disease Activity at Month 6. LDA, MTX
64  2019 Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry. BSA
65  2019 Usefulness of composite indices in the assessment of joint involvement in systemic lupus erythematosus patients: correlation with ultrasonographic score. DAS28, SDAI, SLE, STR, US
66  2019 Ustekinumab is effective in biological refractory Crohn's disease patients-regardless of approval study selection criteria. ---
67  2019 Validity and responsiveness of the Work Functioning Impairment Scale (WFun) in rheumatoid arthritis patients: A multicenter prospective study. HAQ-DI, RA, SDAI, WFun, WPAI
68  2019 Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease. CD, EQ-5D, PDAI, VAS
69  2019 Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3. CR, ECR
70  2018 A comprehensive review and update on Crohn's disease. CD, CT, HBI, IBD, SIBDQ, TNF, UC
71  2018 A New Model Based on 25-Hydroxyvitamin D3 for Predicting Active Crohn's Disease in Chinese Patients. ALB, AUC, CD, CRP, ESR, Hb, PLT, ROC
72  2018 ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI). ACPA, OBRI, RA, RF
73  2018 Affective temperament in inflammatory bowel diseases: Another brick in the wall of differentiation. CD, IBD, UC
74  2018 Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease. AAAs, CRP, FC
75  2018 Association Between Pain Sensitization and Disease Activity in Patients With Rheumatoid Arthritis: A Cross-Sectional Study. PPTs, QST, RA
76  2018 Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn's disease. CD, CRP, LS, SBCE
77  2018 Association of weight loss with improved disease activity in patients with rheumatoid arthritis: A retrospective analysis using electronic medical record data. RA
78  2018 Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study. Azil, DAS28, ETAN, HAQ-DI, RA, RAS, SDAI
79  2018 Biomarker-Based Models Outperform Patient-Reported Scores in Predicting Endoscopic Inflammatory Disease Activity. AUC, CD, FC, Hct, hs-CRP, PROs, SES-CD
80  2018 Cannabis for the treatment of Crohn's disease. AEs, CD, CRP, MD, RR, THC
81  2018 Changes in serum interleukin-6 levels as possible predictor of efficacy of tocilizumab treatment in rheumatoid arthritis. DAS, RA, TCZ
82  2018 Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement. CD, CE, CT, LOC, MR, SB
83  2018 Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials. CD, hNRI
84  2018 Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease. CD, CRP, ESR, IBD, IgA, SES-CD, UC, UCEIS
85  2018 Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis. LDA, OR
86  2018 Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations. DAS28-ESR, RA, SDAI
87  2018 Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries. LDA, RA
88  2018 Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration. bDMARD, DMARDs, LDA, RA, TCZ, TCZ mono, TNF, TNFi mono
89  2018 Comparison of composite indices with global synovitis score on ultrasound for detecting remission. DAS28, GLOESS, RA, SDAI
90  2018 Crohn's disease patient serum changes protein expression in a human mesenchymal stem cell model in a linear relationship to patients' disease stage and to bone mineral density. BMD, CD, GO, SP
91  2018 Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry. DMARD, PRO, RA, TNF
92  2018 Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients. NinJa, RA
93  2018 Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry. PPF, RA, tsDMARD
94  2018 Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-alpha Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study. ABA, RA, TNFi
95  2018 Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis. GC, LDA, MTX, RA
96  2018 Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies. ACR, csDMARD, ESR, GC, HAQ-DI, LDA, MTX, RA, VAS
97  2018 Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. CALM, CDEIS
98  2018 Effectiveness and safety of anti-TNF in psoriatic arthritis patients in Brazil: a post-incorporation analysis. BASDAI, EQ-5D, HAQ-DI
99  2018 Effectiveness of biologics in Australian patients with rheumatoid arthritis: a large observational study: REAL. bDMARD, cDMARD, RA
100  2018 Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study. CD, IBDQ